StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb (BMY) Tops Q3 EPS by 12c; Boosts FY16 Outlook; Approves New $3B Stock Buyback Plan
October 27, 2016 7:00 AM
Bristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $0.77, $0.12 better than the analyst estimate of $0.65. Revenue for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Earnings
Guidance
Hot Buybacks
Hot Earnings
Hot Guidance
Stock Buybacks
Next Articles
Jefferies Raises Price Target on Bristol-Myers Squibb (BMY) Following 3Q
October 28, 2016 8:00 AM
Bristol-Myers Squibb Reports Third Quarter Financial Results
October 27, 2016 6:59 AM
Stocks with Implied Volatility Movement
October 27, 2016 5:21 AM